当前位置:首页 > 文献互助 > 互助详情

Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study复制

用户Lz2LyWF0h8HA 2天前 29 10 已关闭

DOI: 10.1200/jco.2020.38.15_suppl.6012复制

文献链接:复制

其他信息:

互助时间线

2026-03-29 15:01:54 [关闭求助]

楼主用户Lz2LyWF0h8HA关闭了求助

2026-03-29 14:43:40 [发起求助]